Synopsis of recent research by authors named "Mario Kubanik"
- Recent research by Mario Kubanik focuses on the development of organometallic complexes, particularly organoruthenium and organoosmium compounds, aimed at enhancing the efficacy of cancer treatments, including investigations into their biological properties and structure-activity relationships.
- His studies highlight the use of diverse ligands such as benzoylthiourea and 2-pyridinecarbothioamides, exploring their coordination properties and the resulting impact on cytotoxicity and cellular accumulation of metallodrugs in vitro.
- Kubanik also emphasizes the importance of advanced analytical techniques, such as CE-ICP-MS and MEEKC, in elucidating the metabolic pathways and interactions of these metal-based agents, paving the way for improved drug design and therapeutic strategies in oncology.
